The Crucial Vaccine Benefit We're Not Talking about Enough

Trouble viewing? View in your browser. View all Scientific American publications.

    

July 27, 2021

Public Health The Crucial Vaccine Benefit We're Not Talking about Enough They not only prevent people from getting sick; they also cut down on transmission by those who get infected after immunization By Daniel P. Oran,Eric Topol

Computing How Olympic Tracking Systems Capture Athletic Performances The 3-D tracking systems used in Tokyo may one day enable digital twins of athletes By Eleanor Cummins

Physics Learning to Live in Steven Weinberg's Pointless Universe The late physicist's most infamous statement still beguiles scientists and vexes believers By Dan Falk

Climate Enlist the Ocean in Combatting Climate Change, Experts and Advocates Argue "Blue carbon" taken up by marine plants and animals is mostly neglected in climate policy, they say By Sara Schonhardt,E&E News

Medicine A Few Days on Antibiotics Are Often as Good as Weeks, Research Shows Shorter courses cause fewer side effects and breed fewer antibiotic-resistant "superbugs" By Claudia Wallis

The Body This Formula Calculates How Many Calories You Burn If You're Doing Absolutely Nothing When it comes to dieting, here's how to tally the so-called basal metabolic rate By Florian Freistetter

Space Avi Loeb's Galileo Project Will Search for Evidence of Alien Visitation With nearly $2 million in private funding, the controversial new initiative is targeting unidentified phenomena in Earth's skies and beyond By Adam Mann

Environment Pesticides Are Killing the Organisms That Keep Our Soils Healthy They harm worms, beetles and thousands of other subterranean species that are vital to agriculture By Nathan Donley,Tari Gunstone

Neurological Health Immune Cells Suggest New Alzheimer's Treatment Possibilities Brain cells called microglia have different effects as the neurodegenerative disease progresses By Jason Ulrich,David M. Holtzman

Medicine Fauci on COVID Drugs, Vaccines and Getting Back to Normal The U.S.'s top infectious disease specialist describes a new Biden administration program to develop and test antivirals—and what he's most worried about as the nation reopens By Charles Schmidt

FROM THE STORE Special Editions Volume 30, Issue 3s

ADVERTISEMENT

FROM THE ARCHIVE 7 Ways to Reduce Reluctance to Take COVID Vaccines Trusted messengers and repeated reminders can overcome hesitancy, social science shows By Claudia Wallis | March 2021

QUOTE OF THE DAY "The message to those who remain unvaccinated should be: Don't let the virus use you to harm others." Daniel P. Oran and Eric J. Topol, Scripps Research Translational Institute

LATEST ISSUES

Questions?   Comments?

Download the Scientific American App

To view this email as a web page, go here. You received this email because you opted-in to receive email from Scientific American. To ensure delivery please add news@email.scientificamerican.com to your address book. Unsubscribe     Manage Email Preferences     Privacy Policy     Contact Us